WeVote
Log In

Bill

Bill

SF 383

A bill for an act relating to pharmacy benefits managers, pharmacies, prescription drugs, and pharmacy services administrative organizations, and including applicability provisions.

2025-2026 Regular Session

Iowa law regulates pharmacy benefits managers' pricing practices and reimbursement requirements to increase pharmacy transparency and potentially improve prescription drug affordability.

Signed by Governor.
#contracts #drugs #insurance #medicalassistance #medicare #pharmacy #pharmacybenefitsmanagers #prescriptiondrugs #prices #third-partypayors
0
WeVote Research Nonpartisan
Bill Summary · SF 383

Legislative bill overview

SF 383 is an Iowa law regulating pharmacy benefits managers (PBMs), the intermediaries that manage prescription drug benefits for insurance plans. The bill establishes requirements for PBM operations, pharmacy reimbursement practices, and transparency in prescription drug pricing. It became law in June 2025 after receiving the Governor's signature.

Why is this important

PBMs significantly influence medication costs and pharmacy accessibility for Iowa residents. The regulations in this bill affect drug pricing practices, pharmacy profit margins, and how insurance claims are processed—factors that directly impact medication affordability and which pharmacies remain viable. This type of legislation has become increasingly common as states seek to address rising prescription drug costs and pharmacy closures.

Potential points of contention

  • PBM business model impact: Stricter regulations may increase administrative costs for PBMs, potentially passed to insurers and employers, or reduce their profit margins depending on specific provisions
  • Pharmacy access vs. cost control: Requirements favoring independent pharmacies may increase costs for large plans, while PBM restrictions could reduce negotiating power that keeps drug prices competitive
  • Implementation complexity: New regulatory requirements create compliance costs and administrative burden for affected entities, particularly smaller pharmacies or PBMs

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.